Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
May enable safer cosmid-based HSV-1 amplicon packaging; leaves open therapeutic translation in cardiovascular models.
Laimbacher et al. (2012) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: